BSC
GILD icon

Brown Shipley & Co’s Gilead Sciences GILD Stock Holding History

Brown Shipley & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-71
Closed -$5.47K – 109
2023
Q2 		$5.47K Hold
71
– – ﹤0.01% 117
2023
Q1 		$5.89K Buy
+71
New +$5.88K ﹤0.01% 111

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Shipley & Co's GILD Position: Q3 2023 in Review

Brown Shipley & Co sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 71 shares — an estimated $5.47K sold.

Brown Shipley & Co first reported a position in GILD in Q1 2023 and held it in 2 quarters. The position peaked at $5.89K in Q1 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Brown Shipley & Co reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Brown Shipley & Co sold 71 Gilead Sciences shares in Q3 2023, an estimated $5.47K.
  • Brown Shipley & Co first reported a position in Gilead Sciences in Q1 2023 and held it in 2 quarters.
  • Brown Shipley & Co's Gilead Sciences position peaked at $5.89K in Q1 2023.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Brown Shipley & Co's 13F filing for Q3 2023, filed 21 Nov 2023.